Prudential Financial’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-784
Closed -$13.5K 2405
2025
Q4
$13.5K Sell
784
-851
-52% -$16.5K ﹤0.01% 2202
2025
Q3
$42.1K Hold
1,635
﹤0.01% 2356
2025
Q2
$94K Buy
1,635
+677
+71% +$54.3K ﹤0.01% 2293
2025
Q1
$104K Buy
958
+10
+1% +$870 ﹤0.01% 2123
2024
Q4
$45K Hold
948
﹤0.01% 2220
2024
Q3
$93.1K Sell
948
-43
-4% -$5.55K ﹤0.01% 2584
2024
Q2
$162K Buy
+991
New +$141K ﹤0.01% 2506
2022
Q1
Sell
-3,346
Closed -$2.32M 2607
2021
Q4
$2.32M Buy
3,346
+269
+9% +$164K ﹤0.01% 1457
2021
Q3
$2.02M Buy
+3,077
New +$2.63M ﹤0.01% 1462

Other funds holding AGL

Prudential Financial's AGL Position: Q1 2026 in Review

Prudential Financial sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 784 shares — an estimated $13.5K sold.

Prudential Financial first reported a position in AGL in Q3 2021 and held it in 9 quarters. The position peaked at $2.32M in Q4 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Prudential Financial reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Prudential Financial sold 784 Agilon Health shares in Q1 2026, an estimated $13.5K.
  • Prudential Financial first reported a position in Agilon Health in Q3 2021 and held it in 9 quarters.
  • Prudential Financial's Agilon Health position peaked at $2.32M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.